Analyst Reco. Novo Nordisk A/S BOERSE MUENCHEN

Equities

Real-time BOERSE MUENCHEN Other stock markets 15:51:25 2024-07-04 EDT			5-day change	1st Jan Change
130.5 ^EUR	+0.77%		-3.33%	+39.42%

07-04	ETF of the week: Investing in strong trends with the momentum theme
07-04	NOVO NORDISK : Deutsche Bank remains its Buy rating	ZD

NOVO NORDISK : Deutsche Bank remains its Buy rating	07-04	ZD
AlphaValue/Baader Europe Upgrades Novo Nordisk to Buy from Add, Lifts PT	07-04	MT
Top Midday Stories: Southwest Board Approves Shareholder Rights Plan; National Amusements Agrees to Preliminary Deal to Sell Paramount to Skydance; Ozempic, Wegovy Linked to Blinding Eye Condition, Study Says	07-03	MT
NOVO NORDISK : Berenberg reiterates its Neutral rating	07-03	ZD
NOVO NORDISK : Buy rating from Goldman Sachs	07-03	ZD
US President Calls Out Eli Lilly, Novo Nordisk Over High Drug Prices	07-02	MT
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say	07-02	MT
Biden says Novo Nordisk must cut prices of diabetes, weight loss drugs	07-02	RE
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say in USA Today Op-Ed	07-02	MT
NOVO NORDISK : Jefferies reiterates its Sell rating	07-02	ZD
NOVO NORDISK : UBS gives a Neutral rating	06-28	ZD
NOVO NORDISK : JP Morgan gives a Buy rating	06-27	ZD
NOVO NORDISK : Goldman Sachs reiterates its Buy rating	06-27	ZD
AlphaValue/Baader Europe Downgrades Novo Nordisk to Add from Buy, Raises PT	06-26	MT
NOVO NORDISK : Deutsche Bank remains its Buy rating	06-25	ZD
NOVO NORDISK : Jefferies reiterates its Sell rating	06-24	ZD
NOVO NORDISK : Gets a Buy rating from JP Morgan	06-24	ZD
India's Biocon seeks partner to test generic Wegovy, Ozempic in China	06-20	RE
NOVO NORDISK : Deutsche Bank remains its Buy rating	06-20	ZD
NOVO NORDISK : Deutsche Bank reiterates its Buy rating	06-14	ZD